Carbonic anhydrase I and II autoantibodies in Behçet's disease.
Carbonic anhydrase I and II autoantibodies in Behçet's disease.
复制标题
白塞病中的碳酸酐酶 I 和 II 自身抗体。
DOI:
--
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
I. Turan
中科院分区:
文献类型:
--
作者:
A. Menteşe;A. Alver;S. Demir;A. Sumer;Serap Ozer Yaman;M. Karkucak;Arzu Aydin Çapkin;Diler Us Altay;I. Turan
BACKGROUND
Behçet's disease is a vasculitis, seen more frequently around the Mediterranean and the Far East, and evinces with oral and genital ulcerations, skin lesions and uveitis. Carbonic anhydrase (CA) is a metalloenzyme which is widely distributed in the living world, and it is essential for the regulation of acid-base balance. Anti-CA antibodies have been reported in many disorders, such as systemic lupus erythematosus, Sjögren's syndrome, rheumatoid arthritis, endometriosis, idiopathic chronic pancreatitis, type 1 diabetes and Graves' disease. The goal of this study was to investigate CA I and II autoantibodies in Behçet's disease (BD).
METHODS
35 patients with BD and 29 healthy controls were included in the study and CA I and II autoantibody levels were investigated by ELISA.
RESULTS
The CA I and II autoantibody levels of BD group were significantly higher than the healthy group (p=0.013, p inf 0.0001, respectively). A cut-off value of 0.250 ABSU for anti-CA I was associated with 34 % sensitivity and 100 % specificity and a cut-off value of 0.171 ABSU for anti-CA II was associated with 54 % sensitivity and 100 % specificity for predicting BD.
CONCLUSION
The CA I and II autoantibody levels in patients with BD were found higher compared to control group and the results suggest that CA I and II autoantibodies may be involved in the pathogenesis of BD.